TrialThe European journal of contraception & reproductive health care : the official journal of the European Society of Contraception2016

Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study.

Spyros A Kalams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.